Cargando…
Content and Method of Information for Participants in Clinical Studies With Induced Pluripotent Stem Cells (iPSCs)
Research with induced pluripotent stem cells (iPSCs) involves specific ethical challenges, which should be addressed in the informed consent process. Up to now, little concern has been paid to the practice of information in iPSC-clinical studies. In order to fill this research gap, we have searched...
Autores principales: | Orzechowski, Marcin, Schochow, Maximilian, Kühl, Michael, Steger, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113756/ https://www.ncbi.nlm.nih.gov/pubmed/33996790 http://dx.doi.org/10.3389/fcell.2021.627816 |
Ejemplares similares
-
Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs)
por: Orzechowski, Marcin, et al.
Publicado: (2020) -
Decoding Genetics of Congenital Heart Disease Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs)
por: Lin, Hui, et al.
Publicado: (2021) -
MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022) -
Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering
por: Gähwiler, Eric K. N., et al.
Publicado: (2021) -
Pannexin 1 Influences Lineage Specification of Human iPSCs
por: Noort, Rebecca J., et al.
Publicado: (2021)